Like Amgen, Glaxo also was charged with criminal misbranding and civil False Claims Act liability.

FORBES: Off-Label Pharma Prosecutions Won't Be Silenced By First Amendment Decision

Biotechnology giant Amgen today pleaded guilty in federal court to a misdemeanor charge of misbranding Aranesp (darbepoetin alfa), its highly successful anemia drug.

FORBES: Amgen Pleads Guilty To Misbranding Anemia Drug Aranesp

Edward Valencia, 51, Federico Valencia, 58, and Rose Marie Cuellar, 20, were arrested on misdemeanor charges of misbranding a drug in violation of the federal Food, Drug, and Cosmetic Act.

NPR: Feds Raid 17 Calif. Businesses For Nitrous Oxide